iTeos Therapeutics Inc (NASDAQ: ITOS) is up 30% today after announcing plans of a registered direct offering. Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins. iTeos Therapeutics stock pops on Q1 earnings Copy link to section The biotechnology company will sell a total of 1,142,857 shares at $17.50 each which translates to a 44% premium on its previous close. The offering will also include “pre-funded warrants to purchase up to 5,714,285 shares”, as pe ...